Prescient Therapeutics (ASX:PTX) has reported a 32.3% reduction in net loss for the half-year ended 31 December 2024, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback